324 related articles for article (PubMed ID: 15899791)
21. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.
Zhong Q; Boyer TG; Chen PL; Lee WH
Cancer Res; 2002 Jul; 62(14):3966-70. PubMed ID: 12124328
[TBL] [Abstract][Full Text] [Related]
22. Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage.
Adachi N; Iiizumi S; So S; Koyama H
Biochem Biophys Res Commun; 2004 Jun; 318(4):856-61. PubMed ID: 15147950
[TBL] [Abstract][Full Text] [Related]
23. Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks.
Tichy ED; Pillai R; Deng L; Liang L; Tischfield J; Schwemberger SJ; Babcock GF; Stambrook PJ
Stem Cells Dev; 2010 Nov; 19(11):1699-711. PubMed ID: 20446816
[TBL] [Abstract][Full Text] [Related]
24. Nonhomologous end joining and V(D)J recombination require an additional factor.
Dai Y; Kysela B; Hanakahi LA; Manolis K; Riballo E; Stumm M; Harville TO; West SC; Oettinger MA; Jeggo PA
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2462-7. PubMed ID: 12604777
[TBL] [Abstract][Full Text] [Related]
25. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes.
Grawunder U; Zimmer D; Fugmann S; Schwarz K; Lieber MR
Mol Cell; 1998 Oct; 2(4):477-84. PubMed ID: 9809069
[TBL] [Abstract][Full Text] [Related]
26. The embryonic lethality in DNA ligase IV-deficient mice is rescued by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ mutants.
Karanjawala ZE; Adachi N; Irvine RA; Oh EK; Shibata D; Schwarz K; Hsieh CL; Lieber MR
DNA Repair (Amst); 2002 Dec; 1(12):1017-26. PubMed ID: 12531011
[TBL] [Abstract][Full Text] [Related]
27. Lysine 271 but not lysine 210 of XRCC4 is required for the nuclear localization of XRCC4 and DNA ligase IV.
Fukuchi M; Wanotayan R; Liu S; Imamichi S; Sharma MK; Matsumoto Y
Biochem Biophys Res Commun; 2015 Jun; 461(4):687-94. PubMed ID: 25934149
[TBL] [Abstract][Full Text] [Related]
28. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts.
Karanjawala ZE; Grawunder U; Hsieh CL; Lieber MR
Curr Biol; 1999 Dec 16-30; 9(24):1501-4. PubMed ID: 10607596
[TBL] [Abstract][Full Text] [Related]
29. Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.
Koch CA; Agyei R; Galicia S; Metalnikov P; O'Donnell P; Starostine A; Weinfeld M; Durocher D
EMBO J; 2004 Oct; 23(19):3874-85. PubMed ID: 15385968
[TBL] [Abstract][Full Text] [Related]
30. Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.
Daniel R; Greger JG; Katz RA; Taganov KD; Wu X; Kappes JC; Skalka AM
J Virol; 2004 Aug; 78(16):8573-81. PubMed ID: 15280466
[TBL] [Abstract][Full Text] [Related]
31. In vitro rejoining of double strand breaks in genomic DNA.
Iliakis G; Mladenov E; Cheong N
Methods Mol Biol; 2012; 920():471-84. PubMed ID: 22941623
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of novel SCR7-based small-molecule inhibitor of DNA end-joining, SCR130 and its relevance in cancer therapeutics.
Ray U; Raul SK; Gopinatha VK; Ghosh D; Rangappa KS; Mantelingu K; Raghavan SC
Mol Carcinog; 2020 Jun; 59(6):618-628. PubMed ID: 32189406
[TBL] [Abstract][Full Text] [Related]
34. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
[TBL] [Abstract][Full Text] [Related]
35. In vitro rejoining of double-strand breaks in genomic DNA.
Iliakis G; Cheong N
Methods Mol Biol; 2006; 314():95-108. PubMed ID: 16673877
[TBL] [Abstract][Full Text] [Related]
36. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
[TBL] [Abstract][Full Text] [Related]
37. Long-term XPC silencing reduces DNA double-strand break repair.
Despras E; Pfeiffer P; Salles B; Calsou P; Kuhfittig-Kulle S; Angulo JF; Biard DS
Cancer Res; 2007 Mar; 67(6):2526-34. PubMed ID: 17363570
[TBL] [Abstract][Full Text] [Related]
38. Autocyclized and oxidized forms of SCR7 induce cancer cell death by inhibiting nonhomologous DNA end joining in a Ligase IV dependent manner.
Vartak SV; Swarup HA; Gopalakrishnan V; Gopinatha VK; Ropars V; Nambiar M; John F; Kothanahally SKS; Kumari R; Kumari N; Ray U; Radha G; Dinesh D; Pandey M; Ananda H; Karki SS; Srivastava M; Charbonnier JB; Choudhary B; Mantelingu K; Raghavan SC
FEBS J; 2018 Nov; 285(21):3959-3976. PubMed ID: 30230716
[TBL] [Abstract][Full Text] [Related]
39. The non-homologous end-joining pathway is not involved in the radiosensitization of mammalian cells by heat shock.
Dynlacht JR; Bittner ME; Bethel JA; Beck BD
J Cell Physiol; 2003 Sep; 196(3):557-64. PubMed ID: 12891712
[TBL] [Abstract][Full Text] [Related]
40. Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro.
Lee JW; Yannone SM; Chen DJ; Povirk LF
Cancer Res; 2003 Jan; 63(1):22-4. PubMed ID: 12517771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
